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Abstract
Background: Characteristic complications have been reported for transconjunctival sutureless vitrectomy, such as
postoperative sclerotomy leakage and postoperative hypotony. Particular attention to sclerotomy closure is required
in cases of silicone oil tamponade, because postoperative supplementation of silicone oil implies reoperation, whereas
postoperative supplement of gas is comparatively easy. This study investigated sclerotomy closure in cases of silicone
oil tamponade using 25-gauge transconjunctival sutureless vitrectomy.
Methods: We enrolled 19 consecutive eyes with silicone oil injection (Group A, self-sealing sclerotomies, n = 10)
(Group B, sutured sclerotomies, n = 9) and 10 eyes with silicone oil removal (Group C, self-sealing sclerotomies)
using 25-gauge TSV. Postoperative intraocular pressure was compared between Groups A and B, and between Groups
A and C using repeated-measures analysis of variance (ANOVA), one-way factorial ANOVA, and the Tukey-Kramer test.
Results: No significant differences in age or axial length were seen among groups, but surgical time differed significantly
between Group C and the other groups. Mean duration of silicone oil tamponade was 3.2 ± 1.4 months in
Group C, and no sclerotomies in Group A or C required suture placement. Postoperative silicone oil leakage
to the subconjunctival space was not encountered in Group A. No cases showed postoperative hypotony
(defined as intraocular pressure <5 mmHg). Significant differences in intraocular pressure within the same
postoperative period were not identified between Groups A and B. Conversely, significant differences in
intraocular pressure within the same postoperative period were identified at postoperative days 1 and 2,
although not at postoperative week 1 or postoperative month 1 between Groups A and C.
Conclusions: The procedure for sclerotomy closure seems to have little influence on postoperative intraocular
pressure in eyes with silicone oil tamponade using 25-gauge transconjunctival sutureless vitrectomy, because silicone
oil tamponade may avoid postoperative hypotony by decreasing sclerotomy leakage in the early postoperative period.
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Background
The 25-gauge transconjunctival sutureless vitrectomy
(TSV) first reported by Fujii et al. [1] in 2002 and the
23-gauge TSV described by Eckardt et al. [2] in 2005
have become more common in recent years. The char-
acteristic procedure in TSV compared with conventional
20-gauge vitreotomy is sutureless sclerotomy; in other
words, self-sealing sclerotomy. Potential advantages of
TSV over conventional 20-gauge vitrectomy include faster
wound-healing, reduced conjunctival scarring, greater
patient comfort, decreased postoperative inflammation,
reduced postoperative astigmatic changes, and shorter
surgical opening and closing times [3]. However, charac-
teristic complications of TSV have been reported to include
postoperative sclerotomy leakage and postoperative
hypotony [4–9], so surgeons have been apprehensive
about the potential weakness of self-sealing sclerotomy.
Preventing weakness of the self-sealing sclerotomy has
been examined in several articles. Lin et al. [10] suggested
that using an oblique sclerotomy incision rather than a
conventional sclerotomy incision reduced the incidence of
postoperative sclerotomy leakage because of its natural
self-sealing effect, and Shimozono et al. [11] found that a
three-step incision, similar to the self-sealing incision in
cataract surgery, reduced postoperative hypotony. Amato
et al. [4] suggested that leakage-related complications
occurred, especially in previously vitrectomized eyes, due
to the failure of peripheral vitreous to plug the unsutured
sclerotomy. The mechanisms of self-sealing sclerotomy
would thus appear to involve adherence between the
internal and external valves and vitreous incarceration
in the sclerotomy. Although the mechanisms underlying
self-sealing sclerotomy appear to have been resolved, a
fear of the weakness of self-sealing sclerotomy is still
encountered. On the other hand, Cibis et al. [12] first
reported silicone oil (SO) tamponade for vitreoretinal
surgery in 1962, and SO tamponade has since seen
wide use for severe vitreoretinal disease. Song et al.
[13] described shrinkage of the vitreous basal gel in SO
extraction cases because of previous tamponade. If much
remnant vitreous remains, there will be a possibility of
severe complications such as proliferative vitreoretinopathy
after the surgery due to postoperative shrinkage of vitreous
gel, so thorough intraoperative peripheral vitrectomy is
required ahead of SO tamponade. However, perform-
ing thorough peripheral vitrectomy reduces vitreous
incarceration into the sclerotomy, which is one of the
self-sealing factors at the end of surgery. Colyer et al. [5]
described a key concern with inferior rhegmatogenous
retinal detachment as reduction in the efficacy of endo-
tamponade due to postoperative leakage of gas through
self-sealing sclerotomy. Similarly, postoperative leakage of
SO through the sclerotomy may influence the success of
surgery. Furthermore, we should pay particular attention
to sclerotomy closure in cases of SO tamponade, because
postoperative supplementation of SO implies reoperation,
whereas postoperative supplement of gas is comparatively
easy. This study examined sclerotomy closure in cases of
SO tamponade using 25-gauge TSV.
Methods
This retrospective study was approved by the institutional
committee of National Hospital Organization Sagamihara
Hospital, and complied with the tenets of the Declaration
of Helsinki. Written informed consent was obtained from
all patients after explanation of the study. We enrolled 19
consecutive eyes of 17 patients with injection of 1000
centistokes of SO (SILIKON1000®; Alcon Laboratories,
Fort Worth, TX) and 10 eyes of 10 patients with
removal of 1000 centistokes of SO (SILIKON1000®)
treated using 25-gauge TSV at our hospital from May 2013
through August 2014. Patients who had undergone buckle
procedure or gas tamponade were excluded. Each surgery
was performed by the same surgeon (H.T.), and TSV was
performed with the Alcon 25-gauge system (TOTAL
PLUS®/Viscous Fluid Control Pak®/Constellation®; Alcon
Laboratories). Oblique incisions were made vertical to the
limbus at an angle of 45° to the sclera and cannulas were
placed 3.5 mm posterior to the limbus using the 25-gauge
EDGEPLUS® trocar/cannula system (Alcon Laboratories).
The sclerotomy for intraocular infusion (infusion site)
was made in the inferotemporal quadrant, and sclerotomies
for intraocular manipulation, such as using a pneumatic
vitreous cutter, endolaser probe, and endoilluminator
(manipulation sites), were made in the superonasal and
superotemporal quadrants. Sclerotomies in vitrectomized
eyes, such as SO removal, were placed in a position
that sufficiently avoided the sclerotomy scar of the
previous vitrectomy. Thorough peripheral vitrectomy and
confirmation of remnant vitreous with a wide-angle viewing
system (Resight®; Carl Zeiss, San Leandro, CA) and scleral
indentation was performed to prevent complications caused
by postoperative shrinkage of the remnant vitreous, and
lensectomy was added in phakic eyes to allow thorough
peripheral vitrectomy and to prevent SO-induced cataract
formation [14]. At the end of surgery, scleral massage was
performed to allow self-sealing of the sclerotomy in cases
of SO injection from January 2014 through August 2014
(Group A, n = 10), while a suture was placed to close the
sclerotomy in cases of SO injection from May 2013 through
December 2013 (Group B, n = 9). Conversely, in all cases of
SO removal, balanced salt solution (BSS Plus®; Alcon
Laboratories) was exchanged directly, and scleral massage
was performed to allow self-sealing of the sclerotomy
(Group C, n = 10). Because all cases of SO removal were
performed thorough vitrectomy at previous surgery, the
condition of remnant vitreous in cases of SO removal were
considered to more closely resemble the cases of SO
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injection than the cases in which thorough vitrectomy was
not performed. The conditions of sclerotomy self-sealing
were defined as no existence of increasing bleb formation
and normal intraocular pressure (IOP) as checked by tactile
examination. If these conditions were not met despite
performing scleral massage for about 1 min, a suture was
placed at the sclerotomy. Patients in whom SO was injected
(Groups A and B) were asked to maintain a facedown
position for a few days postoperatively, while patients who
underwent SO removal (Group C) were not. The following
two comparisons were performed in our study.
Comparisons between Groups A and B
In these groups, SO was injected similarly, but the
treatment of sclerotomy differed (Group A, self-sealing;
Group B, suture placement).
Comparisons between Groups A and C
In both these groups, treatment of sclerotomy involved
self-sealing, but the material injected was different
(Group A, SO; Group C, balanced salt solution).
Repeated-measures analysis of variance (ANOVA) was
used to compare IOP at the following postoperative
period in both groups: postoperative day (POD)1, POD2,
postoperative week (POW)1, and postoperative month
(POM)1. Furthermore, if a significant difference was iden-
tified, one-way factorial ANOVA and the Tukey-Kramer
test were used to pinpoint which factors were significantly
different. Statistical analysis was performed using statistical
software programmed by Hisae Yanai (Statcal-3; OMS
Publication, Saitama, Japan) along with Excel software
(Microsoft, Redmond, WA). Values of p less than 0.05
were considered statistically significant.
Results
The indications for surgery are shown in Table 1 and mean
values for each factor are summarized in Table 2. Mean
axial length was 24.7 mm (range, 22.62–32.64 mm) in
Group A, 25.2 mm (range, 22.05–32.45 mm) in Group B,
and 23.9 mm (range, 22.05–26.92 mm) in Group C. On
the other hand, mean surgical time was 78.4 min (range,
44–124 min) in Group A, 70.9 min (range, 32–105 min) in
Group B, and 36.2 min (range, 26–53 min) in Group C.
No significant differences were seen among groups in
age (p = 0.74; one-way factorial ANOVA) or axial length
(p = 0.56; one-way factorial ANOVA), but surgical time
differed significantly between Group C and the other
groups (p < 0.05; Tukey-Kramer test). Mean duration of
SO tamponade was 3.2 ± 1.4 months in Group C. No
sclerotomies in Group A or C required suture placement.
Postoperative SO leakage to the subconjunctival space
was not encountered in Group A. In cases of combined
surgery (phacoemulsification and vitrectomy), intra- or
postoperative complications of anterior segment such as
hyphema or papillary block due to fibrinous iritis were not
occurred. Postoperative IOPs in each period are summa-
rized in Table 3, and a column graph for all cases at POD1
are provided in Fig. 1, with no cases showing postopera-
tive hypotony (defined as IOP <5 mmHg). In comparisons
of IOP using repeated-measures ANOVA, no significant
differences were identified between Groups A and B for
either variation between subgroups (p = 0.80) or variation
within subgroups (p = 0.72), while a significant difference
was noted between Groups A and C for variation between
subgroups (p < 0.05), but not for variation within subgroups
(p = 0.24). Additional statistical examination using one-way
factorial ANOVA and the Tukey-Kramer test for the signifi-
cant difference (variation between subgroups between
Groups A and C) proved that significant differences in IOP
within the same postoperative period (p < 0.05) had existed
at POD1 and POD2, although not at POW1 or POM1.Ad-
ditional file 1 (age, surgical time, axial length,and postoper-
ative IOP in each case) is available.
Discussion
Severe sclerotomy leakage was not considered to be present
postoperatively in this study, because no cases showed post-
operative hypotony, and the sclerotomies in Groups A and
C had achieved self-sealing with only restoration of the valve
architecture because of the minimal vitreous incarceration
due to thorough vitrectomy. However, Kapran et al. [15] re-
ported a decrease in IOP caused by subclinical amounts of
leakage in cases of self-sealing sclerotomies at 2 h postopera-
tively, although no significant difference was found between
pre- and postoperative IOP on and after day 1. Hypotony on
the day of surgery causes ciliochoroidal detachment [16],
and once ciliochoroidal detachment has developed, several
weeks is usually required for resolution [17, 18]. A tempor-
ary decrease in IOP due to subclinical amounts of leakage
could thus have caused slight ciliochoroidal detachment in
Groups A and C. If so, subclinical amounts of leakage might
influence IOP during a certain postoperative period.
Table 1 Indications for surgery
PVR PDR
Group A SO injection/self-sealing 6 4
Group B SO injection/suture placement 7 2
Group C SO removal/self-sealing 5 5
Table 2 Mean and range for each factor
Group Age (years) Surgical time (min) Axial length (mm)
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Comparison between Groups A and B (self-sealing vs.
suture placement)
We expected that postoperative IOP would be significantly
lower in Group A than in Group B, because subclinical
amounts of leakage would be present in Group A due to
self-sealing sclerotomy, but barely existed in Group B due
to suture placement. However, no significant difference was
found, and postoperative closure of self-sealing sclerotomy
was largely comparable to that of sutured sclerotomy in the
early postoperative period in the case of SO tamponade.
This suggested two possibilities. First, the subclinical
amounts of leakage might be so small that no significant
difference existed. Second, SO tamponade might erase the
influence of subclinical amounts of leakage on postopera-
tive IOP; that is, SO tamponade might avoid postoperative
hypotony by decreasing sclerotomy leakage.
Comparison between Groups A and C (SO tamponade vs.
BSS® tamponade in self-sealing sclerotomy)
Although Amato et al. [4] reported the weakness of
sclerotomy self-sealing in vitrectomized eyes, no significant
correlation between history of vitrectomy and degree of
difficulty of self-sealing was identified in our previous study
[19]. Furthermore, subclinical amounts of leakage might be
similarly present in both groups due to the use of self-
sealing sclerotomy. We therefore did not expect to find
any significant difference in postoperative IOP between
these groups. However, significant differences were seen
on POD1 and POD2. These differences suggest that
intraocular tamponade materials might influence the early
postoperative closure of the self-sealing sclerotomy and
the possibility that subclinical amounts of leakage exist.
On the other hand, the subclinical amount of leakage or
ciliochoroidal detachment was considered to improve
gradually, to the point where no significant difference
existed at POW1 or POM1. From these two observations,
subclinical amounts of leakage existed in the early postop-
erative period and were decreased by SO tamponade.
Shimada et al. [20] reported that despite not suturing the
25-gauge scleral wounds, thorough peripheral vitrectomy
followed by fluid-air/gas exchange reduced the incidence
of postoperative low intraocular tension. Yamane et al.
[17] suggested that surface tension might have held the
detached ciliary body down in gas-filled eyes. Similarly,
surface tension at the sclerotomy exists in cases of SO
tamponade because of hydrophobic material, but not with
balanced salt solution, and therefore may reduce the
incidence of postoperative low IOP.
As a result, SO tamponade may avoid postoperative
hypotony by decreasing sclerotomy leakage in the early
postoperative period. In fact, although Tahiri et al. [21]
described long duration of surgery as influencing the
early postoperative decrease in IOP, the IOPs on POD1
and POD2 in Group C, for which surgical time had been
significantly shorter than in Group A, were significantly
lower than those in Group A. This might support the
theory that SO tamponade decreases sclerotomy leakage in
the early postoperative period. Some limitations to the
present study need to be considered. First, the sample size
was small, because SO was not used particularly frequently.
Second, the evaluation of vitreous incarceration into
the sclerotomy was not entirely accurate, because

































Fig. 1 All cases of IOP at POD1 (mmHg). Intraocular pressure at postoperative day 1 differed significantly between Group C and the other groups
(p < 0.05; Tukey-Kramer test)
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perfect vitreous shaving and objective judgment of
vitreous incarceration were impossible. Of course,
some investigations in recent years have used optical
coherence tomography to evaluate sclerotomy closure
[16, 17]. Although optical coherence tomography is very
useful to project a picture of the real sclerotomy, the scope
for objective evaluations such as quantification is
considered limited. We therefore used IOP to evaluate
sclerotomy closure in the early postoperative period in this
study. Third, postoperative IOP was not considered to
perfectly reflect postoperative sclerotomy closure, because
severe surgical stress causes ciliary dysfunction. However,
no findings plainly suggested ciliary dysfunction, such as
aqueous flare, in any cases in this study. Evaluation of
postoperative sclerotomy closure using IOP therefore did
not influence the result in this study. Fourth, Group C had
already undergone vitrectomy, unlike Groups A and B.
However, previous vitrectomy was considered to have had
little influence on the results in this study, because at least
2 months had passed since SO injection surgery.
Conclusions
In conclusion, the procedure for sclerotomy closure
(self-sealing or suture placement) seems to have little
influence on postoperative IOP in SO tamponade eyes
using 25-G TSV, because SO tamponade may avoid
postoperative hypotony by decreasing sclerotomy leakage
in the early postoperative period.
Additional file
Additional file 1: Each factor and postoperative IOPs in each period
of each case. (XLS 30 kb)
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